Immunocore Holdings plc
Immunocore Holdings plc is a biotechnology company that has developed a T cell receptor (TCR) therapy. The company focuses on addressing outcomes for patients with cancer, infectious diseases, and autoimmune diseases through immunomodulating medicines.
- T cell receptor therapies
- Immunomodulating medicines
- Clinical trials for cancer and infectious diseases